【结 构 式】 |
【分子编号】24169 【品名】3,5-dichlorobenzaldehyde 【CA登记号】10203-08-4 |
【 分 子 式 】C7H4Cl2O 【 分 子 量 】175.01356 【元素组成】C 48.04% H 2.3% Cl 40.51% O 9.14% |
合成路线1
该中间体在本合成路线中的序号:(III)3,5-Dichlorobenzoic acid (I) is reduced with LiAlH4 to give 3,5-dichlorobenzyl alcohol (II). The latter is selectively oxidized with MnO2, yielding 3,5-dichlorobenzaldehyde (III). The condensation of (III) with methylamine gives the corresponding imine (IV), which can be reduced to the benzylamine (V) either with LiAlH4 or NaBH4. The hydrochloride is precipitated with etheric HCl.
【1】 Meindl, W.R.; et al.; Benzylamines: Synthesis and evaluation of antimycobacterial properties. J Med Chem 1984, 27, 9, 1111. |
【2】 Meindl, W.; Schonenberger, H.; Seydel, J.K.; Dhople, A.M.; ME-93. Drugs Fut 1987, 12, 12, 1108. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 24167 | 3,5-dichlorobenzoic acid | 51-36-5 | C7H4Cl2O2 | 详情 | 详情 |
(II) | 24168 | (3,5-dichlorophenyl)methanol | 60211-57-6 | C7H6Cl2O | 详情 | 详情 |
(III) | 24169 | 3,5-dichlorobenzaldehyde | 10203-08-4 | C7H4Cl2O | 详情 | 详情 |
(IV) | 24170 | N-[(E)-(3,5-dichlorophenyl)methylidene]-N-methylamine | C8H7Cl2N | 详情 | 详情 | |
(V) | 24171 | (3,5-dichlorophenyl)-N-methylmethanamine | C8H9Cl2N | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(II)A process useful for the industrial preparation of eberconazole has been reported: The Wittig condensation of 2-(methoxycarbonyl)benzyl(triphenyl)phosphonium bromide (I) with 3,5-dichlorobenzaldehyde (II) by means of NaH in DMF gives 2-[2-(3,5-dichlorophenyl)vinyl]benzoic acid methyl ester (III), which is hydrolyzed with NaOH in methanol to the corresponding free acid (IV). The hydrogenation of (IV) with H2 over Pd/C in methanol affords 2-[2-(3,5-dichlorophenyl)ethyl]benzoic acid (V), which is cyclized to 2,4-dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-one (VI) by means of polyphosphoric acid. The reduction of (VI) with NaBH4 yields the corresponding carbinol (VII), which is treated with SOCl2 affording the chloride (VIII). Finally, this compound is condensed with imidazole (IX) in refluxing DMF.
【1】 Farrerons Gallemi, C.; Monserrat Vidal, C.; Miquel Bono, I.J. (Laboratorios Salvat SA); Process for the preparation of eberconazol and intermediates thereof. WO 9921838 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 26013 | [2-(methoxycarbonyl)benzyl](triphenyl)phosphonium bromide | C27H24BrO2P | 详情 | 详情 | |
(II) | 24169 | 3,5-dichlorobenzaldehyde | 10203-08-4 | C7H4Cl2O | 详情 | 详情 |
(III) | 26014 | methyl 2-[(E)-2-(3,5-dichlorophenyl)ethenyl]benzoate | C16H12Cl2O2 | 详情 | 详情 | |
(IV) | 26015 | 2-[(E)-2-(3,5-dichlorophenyl)ethenyl]benzoic acid | C15H10Cl2O2 | 详情 | 详情 | |
(V) | 26016 | 2-(3,5-dichlorophenethyl)benzoic acid | C15H12Cl2O2 | 详情 | 详情 | |
(VI) | 14362 | 2,4-dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-one | C15H10Cl2O | 详情 | 详情 | |
(VII) | 14363 | 2,4-dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ol | C15H12Cl2O | 详情 | 详情 | |
(VIII) | 14364 | 2,4,5-trichloro-10,11-dihydro-5H-dibenzo[a,d]cycloheptene | C15H11Cl3 | 详情 | 详情 | |
(IX) | 10255 | Imidazole; 1H-Imidazole | 288-32-4 | C3H4N2 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(I)The reaction of 3,5-dichlorobenzaldehyde (I) with malonic acid and ammonium acetate in refluxing isopropanol gives 3-amino-3-(3,5-dichlorophenyl)propionic acid (II), which is esterified with ethanol and HCl yielding the ethyl ester (III), The condensation of (III) with N-(tert-butoxycarbonyl)glycine succinimidyl ester (IV) by means of TEA in THF affords the glycinamide (V), which is deprotected with HCl in dioxane to afford intermediate (VI). The free amino group of (VI) is then acylated with 3-guanidinobenzoic acid by means of isobutyl chloroformate and NMM in DMF yielding the ethyl ester (VIII) of the target product, which is finally hydrolyzed with LiOH in water.
【1】 Ruminski, P.G.; Clare, M.; Collins, P.W.; Desai, B.N.; Lindmark, R.J.; Rico, J.G.; Rogers, T.E.; Russell, M.A. (Pharmacia Corp.); Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivs. as integrin antagonists. EP 0850221; JP 1999510814; US 6013651; WO 9708145 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 24169 | 3,5-dichlorobenzaldehyde | 10203-08-4 | C7H4Cl2O | 详情 | 详情 |
(II) | 28352 | 3-(3,5-dichlorophenyl)-beta-alanine | C9H9Cl2NO2 | 详情 | 详情 | |
(III) | 28353 | ethyl 3-amino-3-(3,5-dichlorophenyl)propanoate | C11H13Cl2NO2 | 详情 | 详情 | |
(IV) | 16364 | tert-butyl N-[2-[(2,5-dioxo-1-pyrrolidinyl)oxy]-2-oxoethyl]carbamate; N-T-BOC-glycine N-hydroxysuccinimide ester | 3392-07-2 | C11H16N2O6 | 详情 | 详情 |
(V) | 28354 | ethyl 3-([2-[(tert-butoxycarbonyl)amino]acetyl]amino)-3-(3,5-dichlorophenyl)propanoate | C18H24Cl2N2O5 | 详情 | 详情 | |
(VI) | 28355 | ethyl 3-[(2-aminoacetyl)amino]-3-(3,5-dichlorophenyl)propanoate | C13H16Cl2N2O3 | 详情 | 详情 | |
(VII) | 28356 | 3-[[amino(imino)methyl]amino]benzoic acid | C8H9N3O2 | 详情 | 详情 | |
(VIII) | 28357 | ethyl 3-([2-[(3-[[amino(imino)methyl]amino]benzoyl)amino]acetyl]amino)-3-(3,5-dichlorophenyl)propanoate | C21H23Cl2N5O4 | 详情 | 详情 |